Adial Pharmaceuticals Inc (NQ: ADIL )

2.390 USD -0.120 (-4.78%)

Official Closing Price Updated: 5:21 PM EST, Mar 1, 2021 Add to My Watchlist

Price and Volume

Volume	516,404
Open	2.530
Bid (Size)	2.420 (1)
Ask (Size)	2.440 (1)
Prev. Close	2.510
Today's Range	2.340 - 2.610
52wk Range	1.000 - 4.000
Shares Outstanding	5,474,856
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Adial Schedules Town Hall to Discuss Positive Updates Regarding Pharmaceutical Pipeline and Business Expansion

February 26, 2021

Adial Receives $1.425 Million in Net Proceeds from Exercise of Warrants

February 26, 2021

Performance

YTD	+38.15%	+38.15%
1 Month	+11.16%	+11.16%
3 Month	+2.58%	+2.58%
6 Month	+73.19%	+73.19%
1 Year	+69.50%	+69.50%

More News

Adial Pharmaceuticals Achieves 50% Enrollment in ONWARD™ Phase 3 Trial

February 25, 2021

Adial to File Fast Track Application for AD04 with the FDA

February 23, 2021

Adial Pharmaceuticals Closes Acquisition of Purnovate

January 26, 2021

Adial Pharmaceuticals to Present at 23rd Annual ICR Conference

January 11, 2021

Adial Pharmaceuticals Receives Notice of Allowance for Third U.S. Patent Covering AD04 for the Treatment for Opioid Use Disorder

January 11, 2021

Adial Pharmaceuticals Appoints Dr. Jack Reich as Head of Regulatory

December 15, 2020

Adial Pharmaceuticals Schedules Business Update Conference Call to Discuss Planned Acquisition of Purnovate and other Recent Developments

December 10, 2020

Adial Pharmaceuticals Enters Agreement to Acquire Purnovate, a Developer of Potential Therapies for Non-Opioid Pain Reduction and Treatment of Addiction

December 10, 2020

BioMedNewsBreaks – Adial Pharmaceuticals Inc (NASDAQ: ADIL) Featured by M-Vest

February 05, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.